Destination countries
Cancer care access by country
Compare care contexts, public-reference facilities, and recorded clinical trials. This page does not guarantee patient acceptance, service availability, visas, or prices.

China
P0High case volume and broad clinical trial participation, especially in cellular therapy.
View access contextHome country for most TanyaKanker users; care is available through national and regional referral hospitals.
View access contextMalaysia
P0A regional referral destination with many private facilities serving international patients.
View access contextA regional referral destination with short travel time from many Indonesian cities.
View access contextA care system with many early- to late-phase clinical studies.
View access contextActive clinical study networks in Latin America.
View access contextAcademic hospital networks with many clinical studies.
View access contextAcademic cancer centers and multicenter clinical trials.
View access contextLarge service volume with costs that are often lower than several other countries.
View access contextAcademic facilities with early-phase clinical studies.
View access contextAcademic oncology centers with active clinical studies.
View access contextA focus on early detection, advanced endoscopy, and clinical research.
View access contextHigh-volume oncology services with many registered clinical studies.
View access contextAcademic hospital networks with active clinical studies.
View access contextA regional destination for healthcare services, including oncology.
View access contextFacilities with high service volume and many registered studies.
View access contextAcademic centers and a broad clinical trial network.
View access contextLarge academic centers with the highest number of early-phase clinical trials.
View access context